Resveratrol boosts bone for men with metabolic syndrome

Resveratrol increases spinal bone density in men with metabolic syndrome and holds promise as a treatment for osteoporosis, say Danish researchers.

"Our study is the first to reveal resveratrol's potential as an anti-osteoporosis drug in humans," says researcher Dr Marie Juul Ørnstrup of Aarhus University Hospital. "Our findings suggest the compound stimulates bone-forming cells within the body."

Her team used a randomised, double-blinded, placebo-controlled trial to assess bone mineral density and signs of bone formation and resorption in 66 middle